The AML Channel on VJHemOnc is supported by Curis Inc., Pfizer and Jazz Pharmaceuticals The supporters have no influence over the production of the content.
Welcome to The Acute Myeloid Leukemia (AML) Channel
VJHemOnc brings you the latest and greatest global advances related to the classification, diagnosis, treatment, and management of AML. Speaking with world-leading experts, The AML Channel delivers video interviews, podcasts, roundtable discussions and more.
Hot topics frequently covered on The AML Channel include the use of measurable residual disease (MRD) testing to guide treatment, antibody-based treatments and CAR-T cell therapies.